NFE2L2 and polycystic ovary syndrome: In a randomized controlled trial conducted by Gharaei et al. [149], it was discovered that treating patients with polycystic ovaries with astaxanthin led to activation of the Nrf2 axis and increased antioxidant capacity in GCs, indicating its potential in attenuating oxidative stress response in such individuals.